Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial

about

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial

Item

http://www.wikidata.org/entity/Q58761710

description

scientific article published on 20 August 2018

@en

wetenschappelijk artikel

@nl

name

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@en

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@nl

type

Item

label

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@en

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@nl

prefLabel

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@en

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@nl

P1476

Switching inhaled iloprost for ...... tension: the VENTASWITCH Trial

@en

P2093

Alexander Roitenberg

http://www.w3.org/2001/XMLSchema#string

Barbara Stollfuß

http://www.w3.org/2001/XMLSchema#string

Christian Müller

http://www.w3.org/2001/XMLSchema#string

Frank Kleinjung

http://www.w3.org/2001/XMLSchema#string

Manuel J Richter

http://www.w3.org/2001/XMLSchema#string

Sabine Berghaus

http://www.w3.org/2001/XMLSchema#string

Valentin Graeff

http://www.w3.org/2001/XMLSchema#string

P2860

Inhaled Therapies for Pulmonary Hypertension

Inhaled iloprost for severe pulmonary hypertension.

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Prostanoid therapies in the management of pulmonary arterial hypertension.

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Acute hemodynamic effects of nebulized iloprost via the I-neb Adaptive Aerosol Delivery system in pulmonary hypertension.

The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).

Prostacyclin therapies for the treatment of pulmonary arterial hypertension.

In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.

P304

2045894018798921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2045894018798921

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ardeschir Ghofrani

P577

2018-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30124140

http://www.w3.org/2001/XMLSchema#string

P932

6128078

http://www.w3.org/2001/XMLSchema#string